EMEA-000292-PIP01-08-M03

  • Email
  • Help

Overview

Product details for Glybera
Invented nameGlybera
Active substance

Alipogene tiparvovec

Decision numberP/0285/2016
PIP numberEMEA-000292-PIP01-08-M03
Pharmaceutical form(s)Solution for injection
Condition(s)/indication(s)

Treatment of hyperchylomicronaemia

Route(s) of administrationIntramuscular use
PIP applicant

uniQure biopharma B.V.
United States
E-mail: m.agarwal@uniqure.com 
Tel.  +1 3399 707027

Decision typePM: decision on the application for modification of an agreed PIP

Decision